Log In
Print this Print this

fluvoxamine (SME3110)

  Manage Alerts
Collapse Summary General Information
Company Meiji Seika Pharma Co. Ltd.
DescriptionOral selective serotonin reuptake inhibitor (SSRI)
Molecular Target
Mechanism of ActionSerotonin (5-HT) reuptake inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationObsessive compulsive disorder (OCD)
Indication DetailsTreat pediatric obsessive compulsive disorder (OCD)
Regulatory Designation
PartnerAbbVie Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today